From GlobeNewswire: 2025-04-14 19:30:00

INVO Fertility, Inc. (formerly NAYA Biosciences) will focus on building, acquiring, and operating fertility clinics and distributing the FDA-cleared INVOcell device. The company will operate under the new name and stock symbol “IVF”. Additionally, NAYA Therapeutics will operate independently, focusing on the clinical development of bifunctional antibodies. The decision to separate the two areas aims to maximize shareholder value. The Company plans to divest a majority stake in NAYA Therapeutics while retaining a minority position to benefit from potential value appreciation. The new structure allows both businesses to concentrate on their respective opportunities and operations.



Read more at GlobeNewswire: NAYA Biosciences Announces Strategic Decision to Separate